Fund Holdings — Birchview Capital, LP

Total Portfolio Value
$175.66M
Total Bought
$30.21M
Total Sold
$30.66M
Net Transaction
-$448.5K
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
INTELLIA THERAPEUTICS INC(NTLA)315,400445,400+130,0002,8355,7103.25%+2,875
RELMADA THERAPEUTICS INC(RLMD)0409,387+409,38702,8491.62%+2,849
OCULAR THERAPEUTIX INC(OCUL)0320,000+320,00002,7101.54%+2,710
KLA CORPORATION(KLAC)21,88319,883-2,00026,59029,27616.67%+2,686
BRISTOL-MYERS SQUIBB CO(BMY)302,842306,268+3,42616,33518,57510.57%+2,240
CELLDEX THERAPEUTICS INC(CLDX)070,095+70,09502,2231.27%+2,223
BIODESIX INC(BDSX)286,804286,80401,9504,1592.37%+2,208
OVINTIV INC(OVV)107,500107,50004,2136,3813.63%+2,168
COMPASS PATHWAYS LTD(CMPS)0375,000+375,00002,0741.18%+2,074
ENGENE HOLDINGS INC
COM
0250,000+250,00001,7030.97%+1,703
ZENAS BIOPHARMA INC(ZBIO)070,000+70,00001,3690.78%+1,369
UNITED THERAPEUTICS CORP(UTHR)3,0004,500+1,5001,4622,6681.52%+1,207
PACIFIC BIOSCIENCES OF CALIFORNIA INC(PACB)500,0001,500,000+1,000,0009351,9801.13%+1,045
NEKTAR THERAPEUTICS(NKTR)31,00031,00001,3112,2301.27%+920
BIOGEN INC(BIIB)05,000+5,00009170.52%+917
UNIQURE NV(QURE)30,789100,697+69,9087371,6460.94%+910
LIPOCINE INC(LPCN)0111,786+111,78608930.51%+893
LAM RESEARCH CORPORATION(LRCX)40,32936,000-4,3296,9047,6924.38%+788
IDEAYA BIOSCIENCES INC(IDYA)016,860+16,86005620.32%+562
ARCUS BIOSCIENCES INC(RCUS)025,889+25,88905590.32%+559
REGENXBIO INC(RGNX)066,270+66,27005550.32%+555
SOLID BIOSCIENCES INC705,955625,980-79,9753,9824,5072.57%+525
KARYOPHARM THERAPEUTICS INC(KPTI)083,952+83,95204680.27%+468
ROCKET PHARMACEUTICALS INC(RCKT)0127,025+127,02504550.26%+455
VIRIDIAN THERAPEUTICS INC(VRDN)020,100+20,10003930.22%+393
ALKERMES PLC(ALKS)50,00050,00001,3991,7681.01%+369
EQT CORPORATION(EQT)34,61934,61901,8562,2031.25%+348
XENON PHARMACEUTICALS INC(XENE)21,00021,00009411,2210.70%+280
NOVOCURE LTD(NVCR)152,100202,330+50,2301,9672,2051.26%+239
GRACE THERAPEUTICS INC(GRCE)050,000+50,00002320.13%+232
KALVISTA PHARMACEUTICALS INC57,00057,00009211,1470.65%+227
APELLIS PHARMACEUTICALS INC
COM
14,00014,00003525630.32%+212
KYNTRA BIO INC(KYNB)022,566+22,56601530.09%+153
PROTHENA CORP PLC
SHS
441,019449,019+8,0004,2124,3642.48%+153
FREEPORT-MCMORAN CL-B(FCX)18,04618,040-69171,0600.60%+144
QUOIN PHARMACEUTICALS LTD(QNRX)020,000+20,00001320.08%+132
CULLINAN THERAPEUTICS INC(CGEM)20,00020,00002072840.16%+77
CYTOKINETICS INC(CYTK)30,00030,00001,9061,9771.13%+71
ZENTALIS PHARMACEUTICALS INC(ZNTL)17,00017,503+50323410.02%+18
PHARVARIS N V
COM
29,84729,84708288430.48%+15
OUTSET MEDICAL INC(OM)98,91398,882-313673800.22%+13
TRINITY CAP INC(TRIN)20,00020,00002932940.17%+1
VOYAGER THERAPEUTICS INC(VYGR)74,91874,91802942890.16%-5
ELUTIA INC(ELUT)263,018165,094-97,9241821730.10%-9
KAYNE ANDERSON BDC INC(KBDC)20,00020,00002862740.16%-12
DOCGO INC(DCGO)49,90839,573-10,33544250.01%-19
BRIDGEBIO PHARMA INC(BBIO)8,6888,68806656450.37%-19
HALOZYME THERAPEUTICS INC(HALO)10,10010,10006806530.37%-27
CANDEL THERAPEUTICS INC(CADL)60,00060,00003392940.17%-45
AXSOME THERAPEUTICS INC(AXSM)6,0616,000-611,1071,0140.58%-93
ALUMIS INC10,0000-10,000980—-98
ULTRAGENYX PHARMACEUTICAL INC(RARE)62,00062,00001,4261,2990.74%-127
FOGHORN THERAPEUTICS INC(FHTX)281,730281,73001,5211,3470.77%-175
PULMONX CORP(LUNG)250,573250,221-3525543230.18%-231
NEUROCRINE BIOSCIENCES INC(NBIX)27,19027,19003,8563,5822.04%-274
INHIBRX BIOSCIENCES INC(INBX)3,6980-3,6982920—-292
LIQUIDIA TECHNOLOGIES INC(LQDA)10,0000-10,0003450—-345
VERASTEM INC(VSTM)150,000150,00001,1587950.45%-363
ALPHATEC HOLDINGS INC(ATEC)18,0580-18,0583800—-380
GOSSAMER BIO INC(GOSS)138,17618,176-120,00042860.00%-422
CORCEPT THERAPEUTICS INC(CORT)67,20047,200-20,0002,3391,9031.08%-436
APOGEE THERAPEUTICS INC(APGE)16,0009,000-7,0001,2087580.43%-450
VERA THERAPEUTICS INC(VERA)44,00044,00002,2281,7701.01%-458
RAPT THERAPEUTICS INC15,0000-15,0005080—-508
TREACE MEDICAL CONCEPTS INC(TMCI)226,9470-226,9475560—-556
BIOHAVEN LTD59,3650-59,3656700—-670
QUIDELORTHO CORP72,54882,548+10,0002,0721,3560.77%-716
ACADIA PHARMACEUTICALS INC171,000171,00004,5673,8062.17%-761
TRAVERE THERAPEUTICS INC(TVTX)43,00029,200-13,8001,6438680.49%-775
ILLUMINA INC(ILMN)6,0000-6,0007870—-787
COMPASS THERAPEUTICS INC(CMPX)1,592,9381,465,867-127,0718,5547,7544.41%-800
HARROW HEALTH INC(HROW)34,00024,000-10,0001,6668460.48%-820
VENTYX BIOSCIENCES INC100,8270-100,8279100—-910
10X GENOMICS INC(TXG)59,0000-59,0009620—-962
PHATHOM PHARMACEUTICALS INC(PHAT)195,000195,00003,2352,1661.23%-1,069
MASIMO CORP8,2800-8,2801,0770—-1,077
PROTAGONIST THERAPEUTICS INC55,00035,000-20,0004,8043,6892.10%-1,115
BICYCLE THERAPEUTICS PLC462,700463,599+8993,2762,1511.22%-1,125
STOKE THERAPEUTICS INC(STOK)260,000210,000-50,0008,2526,8383.89%-1,415
STRUCTURE THERAPEUTICS INC90,000100,000+10,0006,2604,8202.74%-1,439
IMMUNOME INC(IMNM)130,00050,000-80,0002,7921,0940.62%-1,699
PHREESIA INC(PHR)110,70014,300-96,4001,8731200.07%-1,753
CASTLE BIOSCIENCES INC(CSTL)80,60012,900-67,7003,1353170.18%-2,819
OLEMA PHARMACEUTICALS INC(OLMA)269,000219,000-50,0006,7253,2651.86%-3,460
AMICUS THERAPEUTICS INC
COM
253,0000-253,0003,6030—-3,603
Page 1 of 1
Birchview Capital, LP — 13F Holdings — Q1 2026 | TickerTrail